Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Lifestyle-Related Disease Supplements Market Worth $62 Billion in 2026 | Industry Trends, Opportunities and Strategies to 2031

globenewswire.com
ABT Abbott Laboratories is mentioned as a company covered in a market report on lifestyle-related disease supplements. The article does not provide specific sentiment or performance data for Abbott. HLF Herbalife Nutrition is named as a company included in a market analysis of lifestyle-related disease supplements. The article does not provide specific sentiment or performance information for Herbalife. PFE Pfizer Inc. is mentioned as a company covered in a market report on lifestyle-related disease supplements. The article does not provide specific sentiment or performance data for Pfizer. UL Unilever PLC is listed as a company included in a market analysis of lifestyle-related disease supplements. The article does not offer specific sentiment or performance information for Unilever.

Lifestyle-Related Disease Supplements Market Worth $62 Billion in 2026 | Industry Trends, Opportunities and Strategies to 2031 Dublin, Aug. 10, 2026 (GLOBE NEWSWIRE) -- The "Lifestyle-Related Disease Supplements - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)" has been added to ResearchAndMarkets.com's offering.

The global lifestyle-related disease supplements market is projected to grow from USD 58.34 billion in 2025 to USD 62.62 billion in 2026. By 2031, the market is forecast to reach USD 89.22 billion, registering a compound annual growth rate of 7.35% between 2026 and 2031. Growth is supported by the increasing adoption of preventive healthcare, an aging global population and sustained demand for supplements addressing weight management, cardiovascular health, digestive wellness and metabolic health.

Preventive Healthcare Strengthens Supplement Demand

Government healthcare policies are increasingly prioritizing disease prevention, creating favorable conditions for the lifestyle-related disease supplements market. National health strategies influenced by the World Health Organization's focus on preventing non-communicable diseases are positioning nutritional supplements as part of broader efforts to reduce long-term healthcare burdens.

This transition is particularly evident in developed markets, where aging populations are placing pressure on healthcare systems. According to the Council for Responsible Nutrition, 75% of Americans use dietary supplements, while 91% consider them essential to maintaining their health. Employers are also incorporating supplement-related benefits into workplace wellness programs, expanding institutional demand. Clearer regulatory guidance regarding health claims is further supporting consumer confidence and responsible product development.

Rising Lifestyle-Related Disease Prevalence Drives Market Growth

The increasing incidence of diabetes, obesity, cardiovascular disease and metabolic disorders is generating demand for targeted supplement formulations. NHS Digital reported that more than 3.5 million people in England were diagnosed with type 2 diabetes between 2023 and 2024, while approximately 277,000 had type 1 diabetes.

Urbanization, sedentary behavior and greater consumption of processed foods are contributing to similar health challenges across developing economies. Consumers are consequently seeking evidence-based products designed to support metabolic function, heart health, weight management and digestive wellness. Health-monitoring technologies, including continuous glucose monitoring, are also enabling consumers to assess physiological responses and make more informed purchasing decisions.

Weight-Management Supplements Lead Product Demand

Weight-management supplements accounted for 26.72% of the market in 2025, reflecting heightened concern about obesity and demand for products supporting healthy weight maintenance, energy and metabolic function. Digestive-health supplements are forecast to record an 8.45% CAGR through 2031, driven by expanding research into microbiome diversity and the relationship between digestive and cognitive health.

Heart-health supplements continue to benefit from aging demographics and the global burden of cardiovascular disease. Brain-health products are gaining momentum among consumers seeking cognitive support and stress management, while bone and joint-health supplements retain a stable customer base. Demand is also increasing for sleep, immune health and stress-relief products. Multi-functional formulations combining weight-management, digestive-health and energy-support ingredients are creating opportunities for premium positioning.

Regional Lifestyle-Related Disease Supplements Market Outlook

North America held a leading 31.85% market share in 2025. The region benefits from established supplement consumption, extensive direct-selling networks, strong retail availability and a regulatory environment that supports product commercialization. Recommendations for omega-3 fatty acids, vitamin D and probiotics have also reinforced routine consumer adoption.

Asia-Pacific is projected to achieve an 8.20% CAGR through 2031, making it the fastest-growing regional market. Expansion is being driven by urbanization, broader insurance coverage, diabetes-prevention initiatives and rising disposable incomes in China, India and Southeast Asia. Manufacturers are combining Ayurvedic and Traditional Chinese Medicine ingredients with modern formulations and delivery formats. Government incentives supporting domestic manufacturing and internationally recognized Good Manufacturing Practice standards are strengthening regional production capacity.

Europe maintains consistent demand due to rigorous regulations and high consumer trust. Latin America and the Middle East and Africa offer emerging opportunities supported by expanding urban middle-class populations, although logistics constraints and income disparities remain challenges.

Regulatory Differences Present Market Challenges

Divergent approval processes, labeling requirements and health-claim standards continue to increase compliance costs for supplement manufacturers. Regulatory agencies in Singapore, Japan and India apply different product classifications and ingredient requirements, complicating international expansion. These inconsistencies can delay product launches, restrict the use of selected botanical ingredients and reduce returns on research and development investment.

Additional market restraints include consumer skepticism regarding product claims and competition from functional foods and alternative health products. Nevertheless, advances in formulation, delivery technologies and scientific substantiation are expected to support long-term industry growth.

Report Scope

Companies covered in the lifestyle-related disease supplements market report include Abbott Laboratories, Bayer AG, Amway Corp., Nestle S.A., Herbalife Nutrition, Otsuka Holdings, Swanson Health Products, Mega Lifesciences, Nordic Naturals, NOW Health Group, GNC Holdings, The Bountiful Company, Glanbia PLC, Danone S.A., Pfizer Inc., Unilever PLC, Pharmavite, Blackmores Ltd., DSM-Firmenich, Lonza Capsugel and Sirio Pharma.

The report provides market forecasts in USD, detailed segment and regional analysis, an Excel-based market estimate sheet and three months of analyst support.

For more information about this report visit https://www.researchandmarkets.com/r/mxb5os

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.